Login
Toggle navigation
Videos
Categories
Trending
TAY TWO CO., LTD., based in West Japan, is a comprehensive second-hand retail company focused on reselling pre-owned goods.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Yasuyoshi Mitsumoto is Board Member at Tay Two Co Ltd.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Acast ceo Ross Adams interviewed by Nyhetsbyrån Direkt | Ross Adams, CEO, Acast AB (publ)ACAST:STO
00:10:00
Investing arm within Clocktower Group, Clocktower Technology Ventures partners with phenomenal entrepreneurs|Steve Drobny,Founder and CEO,Clocktower Technology Ventures
00:00:00
Andrew Sudholz, CEO, Japara Healthcare Ltd
00:10:00
John Garrity on Maxim Group's Evolution and Emphasis on Client Relationships
00:10:00
Advanced Remote Sensing & Hyperspectral Data Processing for Mineral Exploration
00:10:00
Invests in early stage, revenue-generating, high-growth companie|Monica Dodi,Founder and Managing Director,Women's Venture Capital Fund
00:00:00
Jason Conroy, CEO, MMJ Phytotech Ltd
00:10:00
CJ Logistics x iHerb partnership story 1 minute summary | Kang Shin-ho, CEO, CJ Logistics Corp12:KSC
00:10:00
Assessing the Sustainability of Contour Global's Dividend - Ted Wainman | Financial Analyst and Trainer | Talk Financials
00:10:00
The Next American Economy: Free Markets and Liberty|Samuel Gregg,Professor,American Institute for Economic Research
00:10:00
Canada's Top Mortgage Finance Leader
00:10:00
Understanding Life Insurance: Key Reasons and Practical Advice | Tyler Gray, Founder, SageOak Financial LLC.